» Articles » PMID: 30284586

Effect of Preoperative Hydromorphone in Patients Undergoing Laparoscopic Radical Gastrectomy. A Double-blind, Randomized and Controlled Trial

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2018 Oct 5
PMID 30284586
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the efficacy of preemptive hydromorphone for laparoscopic radical gastrectomy. Methods: The present prospective and double-blinded study was performed in the The First Hospital, Jilin University, Changchun, China, between July 2017 and April 2018. Fifty patients scheduled for laparoscopic radical gastrectomy were equally randomized into 2 groups, which were administrated different drugs 10 minutes before surgery. Group P (the preemptive hydromorphone group) was administrated 2 mg hydromorphone (2 mL), and Group C (the control group) was administrated 2 mL normal saline intravenously. A standardized general anesthesia were conducted. Blood pressure and heart rate, postoperative morphine consumption, pain intensity, sedation status, and side effects were recorded. Results: Group C had larger intraoperative hemodynamic changes, higher postoperative visual analogue scale score, more morphine consumption and lower overall satisfaction degree than Group P. No difference was found between the 2 groups in sedation status and adverse effects.  Conclusion: Preoperative 2 mg hydromorphone could reduce intraoperative changes of blood pressure and heart rate, postoperative pain intensity, and morphine consumption without an increase of adverse effects.

Citing Articles

Hydromorphone Protects against CO Pneumoperitoneum-Induced Lung Injury via Heme Oxygenase-1-Regulated Mitochondrial Dynamics.

Shi J, Du S, Yu J, Zhang Y, He S, Dong S Oxid Med Cell Longev. 2021; 2021:9034376.

PMID: 33927798 PMC: 8053056. DOI: 10.1155/2021/9034376.

References
1.
Wang J, Pang L, Han W, Li G, Wang N . Effect of preemptive intravenous oxycodone on low-dose bupivacaine spinal anesthesia with intrathecal sufentanil. Saudi Med J. 2015; 36(4):437-41. PMC: 4404477. DOI: 10.15537/smj.2015.4.10706. View

2.
Paparella S . Intravenous HYDROmorphone: can you manage the risk?. J Emerg Nurs. 2011; 37(4):377-80. DOI: 10.1016/j.jen.2011.03.010. View

3.
Holthusen H, Backhaus P, Boeminghaus F, Breulmann M, Lipfert P . Preemptive analgesia: no relevant advantage of preoperative compared with postoperative intravenous administration of morphine, ketamine, and clonidine in patients undergoing transperitoneal tumor nephrectomy. Reg Anesth Pain Med. 2002; 27(3):249-53. DOI: 10.1053/rapm.2002.30669. View

4.
Chang A, Bijur P, Napolitano A, Lupow J, Gallagher E . Two milligrams i.v. hydromorphone is efficacious for treating pain but is associated with oxygen desaturation. J Opioid Manag. 2009; 5(2):75-80. DOI: 10.5055/jom.2009.0008. View

5.
Ricket A, Mateyoke G, Vallabh M, Owen C, Peppin J . A pilot evaluation of a hydromorphone dose substitution policy and the effects on patient safety and pain management. J Pain Palliat Care Pharmacother. 2015; 29(2):120-4. DOI: 10.3109/15360288.2015.1035829. View